The Recall Desk
CriticalFDA (Food)·H-1263-2026·Announced 2026-09-02

FDA Recalls Addall XR Shot Liquid Dietary Supplement

ZMB Enterprises is recalling Addall XR Shot liquid dietary supplements because they contain undeclared ingredients 1,4-DMAA, Phenylethylamine, and Phenibut.

What this means for you

Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.

Our severity reasoning: The source metadata explicitly identifies the agency classification as 'Class I'. According to the severity rubric, an FDA Class I recall corresponds to a score of 5 (Critical).

Plain-English summary

The U.S. Food and Drug Administration (FDA) has issued a Class I recall for Addall XR Shot 1 single bottle, 2 fl. oz., liquid dietary supplements manufactured by ZMB Enterprises. The recall is due to the presence of undeclared ingredients in the product, specifically 1,4-DMAA, Phenylethylamine, and Phenibut.

The affected products were sold between July and December 2025. ZMB Enterprises markets these products online via their website, addallxr.com. The source text does not specify the number of units recalled or the geographic distribution beyond the online sales channel.

Consumers who have purchased this product should stop using it immediately and contact the manufacturer for instructions on how to return the product or obtain a refund. The FDA classifies this as a Class I recall, which is the most serious type of recall, indicating a reasonable probability that the use of or exposure to the violative product will cause serious adverse health consequences or death.

The recalled product

Product
Addall XR Shot 1 single bottle, 2 fl. oz., liquid dietary supplement
Manufacturer
ZMB Enterprises

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • Sold between July - December 2025

Distribution

Distribution scope not specified by the agency.